Nutrition therapy cost analysis in the US: Pre-mixed multi-chamber bag vs compounded parenteral nutrition

Applied Health Economics and Health Policy

Volumn 9, Issue 5, 2011, Pages 281-292

  Turpin, Robin S ^a,b   Canada, Todd ^c   Liu, Frank Xiaoqing ^a   Mercaldi, Catherine J ^d   Pontes Arruda, Alessandro ^e   Wischmeyer, Paul ^f  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNITED BIOSOURCE CORPORATION   (United States)

^e Fernandes Tvora Hospital   (Brazil)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cost analysis; Nosocomial infections; Parenteral nutrition

Indexed keywords

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA BASE; DIET THERAPY; FEMALE; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARENTERAL NUTRITION; UNITED STATES;

ADULT; COMMUNICABLE DISEASES; COSTS AND COST ANALYSIS; DRUG COMBINATIONS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; NUTRITION THERAPY; PARENTERAL NUTRITION; UNITED STATES; YOUNG ADULT;

EID: 80052222712     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11594980-000000000-00000     Document Type: Article

References (49)

1. Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr 2003; 22 (3): 235-9 (Pubitemid 36701637)
2. JoostenKF, Hulst JM. Prevalence of malnutrition in pediatric hospital patients. Curr Opin Pediatr 2008; 20 (5): 590-6
3. Meijers JM, Schols JM, van Bokhorst-de van der Schueren MA, et al. Malnutrition prevalence in the Netherlands: Results of the annual Dutch national prevalence measurement of care problems. Br J Nutr 2009; 101 (3): 417-23
4. Pirlich M, Schütz T, Norman K, et al. The German hospital malnutrition study. Clin Nutr 2006; 25 (4): 563-72 (Pubitemid 44109077)
5. Shum NC, Hui WW, Chu FC, et al. Prevalence of malnutrition and risk factors in geriatric patients of a convalescent and rehabilitation hospital. Hong Kong Med J 2005; 11 (4): 234-42 (Pubitemid 41153244)
6. Waitzberg DL, Caiaffa WT, Correia MI. Hospital malnutrition: The Brazilian national survey (IBRANUTRI): A study of 4000 patients. Nutrition 2001; 17 (7-8): 573-80 (Pubitemid 32633787)
7. Beghetto MG, Koglin G, de Mello ED. Influence of the assessment method on the prevalence of hospital malnutrition: A comparison between two periods. Nutr Hosp 2010; 25 (5): 774-80
8. Norman K, Pichard C, Lochs H, et al. Prognostic impact of disease-related malnutrition. Clin Nutr 2008; 27 (1): 5-15 (Pubitemid 351201859)
9. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001; 7 (2): 174-7 (Pubitemid 32374322)
10. Klevens RM, Edwards JR, Richards CL, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007; 122 (2): 160-6
11. Warren DK, Quadir WW, Hollenbeak CS, et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 2006; 34 (8): 2084-9 (Pubitemid 44305609)
12. Btaiche IF, Chan LN, Pleva M, et al. Critical illness, gastrointestinal complications, andmedication therapy during enteral feeding in critically ill adult patients. Nutr Clin Pract 2010; 25 (1): 32-49
13. Dissanaike S, Shelton M, Warner K, et al. The risk for bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care 2007; 11 (5): R114
14. Opilla M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 2008; 36 (10): S173.e5-8
15. Chapter 797. In: The United States Pharmacopeial Convention. USP 31/NF 26. Rockville (MD): The United States Pharmacopeial Convention, 2008
16. Kastango ES. The cost of quality in pharmacy. J Pharm Technol 2003; 19 (1); 49-52
17. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration - 2008. Am J Health-Syst Pharm 2009; 66 (10): 926-46
18. Trissel LA, Gentempo JA, Anderson RW, et al. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding. Am J Health-Syst Pharm 2005; 62 (3): 285-8 (Pubitemid 40403543)
19. Hansen EW, Nielsen PL. Intrinsic and extrinsic microbial contamination of home total parenteral nutrition manufactured in eva-infusion bags (the i.v. bag). J Clin Pharm Ther 1987; 12 (5): 325-31 (Pubitemid 18081027)
20. Miller SJ. Commercial premixed parenteral nutrition: Is it right for your institution? Nutr Clin Pract 2009 Aug-Sep; 24 (4): 459-69
21. Pichard C, Mühlebach S, Maisonneuve N, et al. Prospective survey of parenteral nutrition in Switzerland: A three-year nation-wide survey. Clin Nutr 2001; 20 (4): 345-50 (Pubitemid 32785476)
22. Planas M, Puiggrós C, Sánchez JR, et al. Use of ready-to-use (RTU) products in home-based parenteral nutrition. Nutr Hosp 2006; 21 (1): 64-70
23. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm 1993 Nov; 50 (11): 2386-98
24. Bing CM. Compliance with the Joint Commission medication management standards. In: Joint Commission Resources, Inc. A guide to JCAHO's medication management standards. Joint Commission Resources Inc. Oakbrook Terrace (IL), 2004: 11-29
25. Kochevar M, Guenter P, Holcombe B, et al. ASPEN statement on parenteral nutrition standardization. JPEN J Parenter Enteral Nutr 2007 Sep-Oct; 31 (5): 441-8 (Pubitemid 47357113)
26. Gates DM, Smolarek RT, Stevenson JG. Outsourcing the preparation of parenteral nutrient solutions. Am J Health- Syst Pharm 1996; 53 (18): 2176-8 (Pubitemid 26313619)
27. Dickson LB, Somani SM, Herrmann G, et al. Automated compounder for adding ingredients to parenteral nutrient base solutions. Am J Hosp Pharm 1993; 50 (4): 678-82 (Pubitemid 23096754)
28. Ryan DM, Daniels CE, Somani SM. Personnel costs and preparation time in a centralized intravenous admixture program. Am J Hosp Pharm 1986; 43 (5): 1222-5 (Pubitemid 16118199)
29. Petros WP, Shank Jr WA. A standardized parenteral nutrition solution: Prescribing, use, processing, and material cost implications. Hosp Pharm 1986; 21 (7): 648-9, 654-6
30. Turpin R, Canada T, Rosenthal V, et al. Bloodstream infections associated with parenteral nutrition preparation methods in the United States: A retrospective, large database analysis. JPEN J Parenter Enteral Nutr. In press
31. Mercaldi CJ, Reynolds MW, Turpin RS. Methods to identify and compare parenteral nutrition administered from hospital compounded and premixed multi-chamber bags in a retrospective hospital claims database. JPEN J Parenter Enteral Nutr. Epub 2011 Jul 12
32. Duan N. Smearing estimate: A nonparametric retransformation method. J Amer Statist Assoc 1983; 78: 605-10
33. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratios in cohort studies of common outcomes. JAMA 1998 Nov 18; 280 (19): 1690-1 (Pubitemid 28532993)
34. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009; 33 (3): 277-316
35. Franzetti F, Borghi B, Raimondi F, et al. Impact on rates and time to first central vascular-associated bloodstream infection when switching from open to closed intravenous infusion containers in a hospital setting. Epidemiol Infect 2009; 137 (7): 1041-8
36. Rangel-Frausto MS, Higuera-Ramirez F, Martinez-Soto J, et al. Should we use closed or open infusion containers for prevention of bloodstream infections? Ann Clin Microbiol Antimicrob 2010 Feb 2; 9: 6
37. Rosenthal V, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. Am J Infect Control 2004; 32 (3): 135-41 (Pubitemid 38620834)
38. Vilins M, Blecher S, Silva MA, et al. Rate and time to develop first central line-associated bloodstream infections when comparing open and closed infusion containers in a Brazilian hospital. Braz J Infect Dis 2009; 13 (5): 335-40
39. Agency for Healthcare Research and Quality. State Inpatient Databases (SID). Healthcare Cost and Utilization Project (HCUP). Rockville (MD): Agency for Healthcare Research and Quality, 2007 [online]. Available from URL: Http://www. hcup-us.ahrq.gov/sidoverview.jsp [Accessed 2010 June 9]
40. Agency for Healthcare Research and Quality. Databases and related tools from the Healthcare Cost and Utilization Project (HCUP): Fact sheet[AHRQpublication no. 09-PFS003]. Rockville (MD): AHRQ, 2009 May [online]. Available from URL: Http://ahrq.gov/data/hcup/datahcup.htm [Accessed 2010 June 9]
41. Neumayer LA, Smout RJ, Horn HG, et al. Early and sufficient feeding reduces length of stay and charges in surgical patients. J Surg Res 2001; 95 (1): 73-7 (Pubitemid 34948259)
42. Kyle UG, Genton L, Pichard C. Hospital length of stay and nutritional status. Curr Opin Clin Nutr Metab Care 2005; 8 (4): 397-402 (Pubitemid 40863053)
43. Genton L, Mühlebach S, Dupertuis YM, et al. Ergonomic and economic aspects of total parenteral nutrition. Curr Opin Clin Nutr Metab Care 2006; 9 (2): 149-54 (Pubitemid 44090039)
44. Ockenga J, Freudenreich M, Zakonsky R, et al. Nutritional assessment and management in hospitalised patients: Implication for DRG-based reimbursement and health care quality. Clin Nutr 2005; 24 (6): 913-9 (Pubitemid 41782447)
45. Donabedian H. Nutritional therapy and infectious diseases: A two-edged sword. Nutr J 2006 Sep 4; 5: 21
46. Maswoswe JJ, Newcomer DR, Quandt CM. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions. Am J Hosp Pharm 1987; 44 (6): 1376-81 (Pubitemid 17081132)
47. Holton D, Paton S, Conly J, et al. Central venous catheterassociated bloodstream infections occurring in Canadian intensive care units: A six-month cohort study. Can J Infect Dis Med Microbiol 2006; 17: 169-76 (Pubitemid 44197394)
48. Weaver J, Willy M, Avigan M. Informatic tools and approaches in postmarketing pharmacovigilance used by FDA. AAPS J 2008; 10 (1): 35-41
49. Velentgas P, West W, Cannuscio CC, et al. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other nonaspirin non-steroidal anti-inflammatory medications. Pharmacoepidemiol Drug Saf 2006; 15: 641-52 (Pubitemid 44404662)